CUBE vs PTCT · P/E 25, rev $1.07B vs rev $806.8M
CubeSmart (CUBE) versus PTC Therapeutics Inc (PTCT) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported PTCT revenue for 2024-12-31 was $806.8M. Net income was -$363.3M. Revenue was down 14.0% from 2023-12-31 to 2024-12-31. PTCT currently screens at market cap $6.51B.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. PTCT currently screens at market cap $6.51B.
Not investment advice. Open the CUBE and PTCT stock pages for the full models.
Not investment advice.